World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02420288
Date of registration: 08/04/2015
Prospective Registration: No
Primary sponsor: Universidad Politecnica de Madrid
Public title: Effect of Physical Exercise Program on Fetoplacental Growth
Scientific title: Effect of Physical Exercise Program on Fetoplacental Growth: a Randomized Controlled Trial
Date of first enrolment: November 2014
Target sample size: 124
Recruitment status: Active, not recruiting
URL:  https://clinicaltrials.gov/show/NCT02420288
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Investigator, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Spain
Contacts
Name:     Rubén Barakat Carballo, PhD
Address: 
Telephone:
Email:
Affiliation:  Universidad Politécnica de Madrid
Key inclusion & exclusion criteria

Inclusion Criteria:

- Being healthy and able to exercise following American College of Obstetricians and
Gynecologists (ACOG) guidelines

- Being able to communicate in spanish

- Giving birth at Hospital Universitario de Torrejón, Hospital Universitario de Puerta
de Hierro or Hospital Universitario Severo Ochoa (Madrid)

Exclusion Criteria:

- Multiparity

- Obstetrician complications

- Being interested in the study after 18 weeks

- Not having availability to attend to the physical exercise program

- Younger than 18 years old

- Older than 45 years old



Age minimum: 18 Years
Age maximum: 45 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Healthy
Pregnancy
Intervention(s)
Behavioral: Exercise Group
Primary Outcome(s)
Fetal birth weight [Time Frame: At delivery]
Change from baseline in maternal gestational weight [Time Frame: 38-42 weeks of gestation]
Placental weight [Time Frame: At delivery]
Secondary Outcome(s)
Postpartum depression [Time Frame: 0-12 postpartum months]
pH umbilical cord [Time Frame: At delivery]
Pregestational weight and Body Mass Index (BMI) [Time Frame: Before pregnancy]
Apgar score [Time Frame: At delivery]
Maternal delivery outcomes (composite) [Time Frame: At delivery]
Changes from baseline in maternal quality of life [Time Frame: Up to 36 weeks]
Changes from baseline in prenatal depression [Time Frame: Up to 36 weeks]
Fetal glycemia level [Time Frame: At delivery]
Changes from baseline in urinary incontinence [Time Frame: Up to 36 weeks]
Fetal size outcomes [Time Frame: At delivery]
Gestational diabetes [Time Frame: 24-28 weeks]
Secondary ID(s)
INEF-001
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history